Baltimore, Maryland / ACCESSWIRE / July 9, 2014 / Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, announced today that it has released a new research update on ML Capital Group Inc. (OTCQB – MLCG). The Company produces, markets, and sells its products and services under the SuperStar brand name, including vapor pens, mobile applications, and books that cater to the tobacco and medical marijuana marketplace.
The electronic cigarette, or e-cig market, currently generates $3 billion in annual sales and industry experts forecast it could reach the $300 billion mark in the next ten years. A unique design and feature of the Company’s recently launched SuperStar Vapor Pen set is that it can be used with both tobacco based products, as well as medical marijuana or cannabis in the form of liquid, wax, or dry ingredients.
In the Goldman Opportunity Research report on the Company, analyst Rob Goldman outlines his investment thesis.
“This under-the-radar company has a number of trends in its favor. With a steady increase in the number of its distribution and medical marijuana dispensary channels, the Company has already begun to book meaningful initial wholesale and retail sales. Separately, studies indicate e-cigs and vapor pen usage serve as highly effective smoking cessation devices as well as an alternative to traditional tobacco-based cigarettes. Thus, the market could emerge as one of the fastest growing consumer segments in years. The recent $135M purchase of Blue eCigs by Lorillard (NYSE – LO), the 3rd largest tobacco seller in the U.S., demonstrates the huge market opportunity.”
“Just yesterday, Washington State became the second state in the country to open the market for the legal sale of recreational marijuana. Plus, other states and jurisdictions have gotten into the act. On Monday, the State of New York became the 23rd state in the union to legalize and permit the sale and use of medical marijuana, while in the District of Columbia, voters appear to have gotten enough votes to have proposed recreational marijuana approval legislation on the ballot in November. All of these steps can exponentially increase the size of MLCG’s market.”
This press release contains excerpts of our most recently published sponsored research report on ML Capital Group Inc. Since June 2014, Goldman Small Cap Research has been compensated a total of $5500 for research subscription services by the Company, including $1500 for this update. To view the sponsored research update, report, disclosures and disclaimers, or to download the report in its entirety, please visit http://www.goldmanresearch.com/.
About Goldman Small Cap Research: Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and micro cap stock research reports, articles, daily stock market blogs, and popular investment newsletters. Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.
A Goldman Small Cap Research report, update, newsletter, or article is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. Please read all associated full disclosures, disclaimers, and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other agency. To download our research, view our disclosures, or for more information, visit http://www.goldmanresearch.com/.
About ML Capital Group, Inc.
ML Capital Group, Inc.'s primary business consists of producing products and providing services that support the medical marijuana industry and enhances the lives of the patients that have turned to medical marijuana/cannabis to manage their various ailments. The Company currently produces and markets its products and services under the SuperStar brand name, including vapor pens, mobile applications, and books. The Company does not directly engage in the growing, manufacture, or distribution of medical marijuana, cannabis, or cannabis by-products, thus placing it as one of the safest types of companies in the medical marijuana industry.
For more information visit ML Capital Investors Relations: http://www.mlcapitalgroupinc.com/.
Goldman Small Cap ResearchRob Goldman, Analyst410-609-7100[email protected]
Source: Goldman Small Cap Research